Ahn 1996.
Study characteristics | ||
Methods | Study design: randomized controlled, parallel‐group trial Setting/country: Department of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea Dates study conducted: NR |
|
Participants | Inclusion criteria:
Exclusion criteria:
Number of participants randomized: 23 Group 1 (fluoxetine)
Group 2 (placebo)
|
|
Interventions | Group 1: fluoxetine 20 mg daily for first 1 week and 40 mg daily for remaining 5 weeks after breakfast Group 2: multivitamin as placebo daily |
|
Outcomes | Primary outcomes:
Safety outcomes:
|
|
Funding sources | NR | |
Declarations of interest | NR | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Not described. |
Allocation concealment (selection bias) | Unclear risk | Not described. |
Blinding of participants and personnel (performance bias) All outcomes | Low risk | Quote: "participants and investigator were blinded for the randomization," "randomized placebo controlled trial." |
Blinding of outcome assessment (detection bias) Participant‐reported outcomes | Low risk | Quote: "participants and investigator were blinded for the randomization," "randomized placebo controlled trial." |
Blinding of outcome assessment (detection bias) Investigator‐assessed outcomes | Low risk | Quote: "investigator were blinded for the randomization." |
Blinding of outcome assessment (detection bias) IELT | Low risk | Objective measurement that was unlikely to be influenced by blinding. |
Incomplete outcome data (attrition bias) All outcomes | Low risk | All participants included in analysis. |
Selective reporting (reporting bias) | Unclear risk | Unpublished protocol/prespecified outcomes (intercourse frequency, libido) in method were not or were partially reported in the results. |
Other bias | Low risk | No additional sources of bias identified. |